CLINICAL_TRIALS
research
· 2026-03-31
Clinical Trial Update: Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma) [Phase 2]
Summary
Phase 2 clinical trial evaluating Rademikibart as an add-on treatment for acute asthma exacerbation is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Connect Biopharm LLC | Conditions: Asthma Acute | Phase 2 | Status: RECRUITING